BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32060745)

  • 1. Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation.
    Ceccato F; Artusi C; Barbot M; Lizzul L; Pinelli S; Costantini G; Niero S; Antonelli G; Plebani M; Scaroni C
    J Endocrinol Invest; 2020 Aug; 43(8):1105-1113. PubMed ID: 32060745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic accuracy of increased late night salivary cortisol for Cushing's syndrome: a real-life prospective study.
    Ceccato F; Marcelli G; Martino M; Concettoni C; Brugia M; Trementino L; Michetti G; Arnaldi G
    J Endocrinol Invest; 2019 Mar; 42(3):327-335. PubMed ID: 29987756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cushing's Syndrome: Screening and Diagnosis.
    Ceccato F; Boscaro M
    High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.
    Ceccato F; Barbot M; Zilio M; Frigo AC; Albiger N; Camozzi V; Antonelli G; Plebani M; Mantero F; Boscaro M; Scaroni C
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3856-61. PubMed ID: 26274344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.
    Ceccato F; Antonelli G; Frigo AC; Regazzo D; Plebani M; Boscaro M; Scaroni C
    J Endocrinol Invest; 2017 Jul; 40(7):753-760. PubMed ID: 28247215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Cushing's syndrome in obese women with and without polycystic ovary syndrome.
    Putignano P; Bertolini M; Losa M; Cavagnini F
    J Endocrinol Invest; 2003 Jun; 26(6):539-44. PubMed ID: 12952368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test.
    Ueland GÅ; Methlie P; Kellmann R; Bjørgaas M; Åsvold BO; Thorstensen K; Kelp O; Thordarson HB; Mellgren G; Løvås K; Husebye ES
    Eur J Endocrinol; 2017 Jun; 176(6):705-713. PubMed ID: 28298353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparing overnight dexamethasone suppression test, urine free cortisol, and midnight serum cortisol for the initial diagnosis of Cushing' s syndrome].
    Tang TJ; Liu YP; Yu YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):764-8. PubMed ID: 24325108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic performance of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay in obese and overweight patients referred to exclude Cushing's syndrome.
    Belaya ZE; Iljin AV; Melnichenko GA; Rozhinskaya LY; Dragunova NV; Dzeranova LK; Butrova SA; Troshina EA; Dedov II
    Endocrine; 2012 Jun; 41(3):494-500. PubMed ID: 22447310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
    Berndt V; Dahlqvist P; de Verdier J; Ryberg H; Ragnarsson O
    Front Endocrinol (Lausanne); 2022; 13():1028804. PubMed ID: 36506050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary-adrenal axis and peripheral cortisol metabolism in obese patients.
    Ceccato F; Lizzul L; Barbot M; Scaroni C
    Endocrine; 2020 Aug; 69(2):386-392. PubMed ID: 32564190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UTILITY OF A SINGLE LATE-NIGHT PLASMA CORTISOL AND ACTH FOR THE DIAGNOSIS OF CUSHING SYNDROME.
    Jarial KDS; Bhansali A; Mukherjee KK; Pal R; Sharma A; Vashishtha RK; Sukumar SP; Sachdeva N; Walia R
    Endocr Pract; 2018 Feb; 24(2):156-162. PubMed ID: 29144801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and diagnosis of Cushing's syndrome.
    Castro Md; Moreira AC
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1191-8. PubMed ID: 18209856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.
    Ceccato F; Barbot M; Albiger N; Antonelli G; Zilio M; Todeschini M; Regazzo D; Plebani M; Lacognata C; Iacobone M; Mantero F; Boscaro M; Scaroni C
    Endocrine; 2018 Mar; 59(3):510-519. PubMed ID: 28956262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism.
    Palmieri S; Morelli V; Polledri E; Fustinoni S; Mercadante R; Olgiati L; Eller Vainicher C; Cairoli E; Zhukouskaya VV; Beck-Peccoz P; Chiodini I
    Eur J Endocrinol; 2013 Mar; 168(3):289-96. PubMed ID: 23211572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome.
    Castro M; Elias LL; Elias PC; Moreira AC
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.
    Tsagarakis S; Kokkoris P; Roboti C; Malagari C; Kaskarelis J; Vlassopoulou V; Alevizaki C; Thalassinos N
    Clin Endocrinol (Oxf); 1998 May; 48(5):627-33. PubMed ID: 9666875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of late-night and post-overnight dexamethasone suppression salivary cortisone for the investigation of Cushing's syndrome.
    Ng CM; Lam TK; Au Yeung YC; Choi CH; Iu YP; Shek CC; Tiu SC
    Hong Kong Med J; 2017 Dec; 23(6):570-8. PubMed ID: 29026058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.